Semmelweis Publications
  • Main page

    • Lakatos, Botond Semmelweis University affiliated publications (2020-2025)

    Year:
    Order by:
    Authorship:
    Number of publications: 43
    1.
    Human herpesvirus reactivation and its potential role in the pathogenesis of post-acute sequelae of SARS-CoV-2 infection
    Gáspár, Z;Szabó, BG;Ceglédi, A;Lakatos, B
    D1
    GEROSCIENCE
    2025.
    DOI:10.1007/s11357-024-01323-9 (Copy DOI)
    2.
    Complement Overactivation and Consumption Predicts In-Hospital Mortality in SARS-CoV-2 Infection
    Sinkovits, G;Mezo, B;Réti, M;Müller, V;Iványi, Z;Gál, J;Gopcsa, L;Reményi, P;Szathmáry, B;Lakatos, B;Szlávik, J;Bobek, I;Prohászka, ZZ;Förhécz, Z;Csuka, D;Hurler, L;Kajdácsi, E;Cervenak, L;Kiszel, P;Masszi, T;Valyi-Nagy, I;Prohászka, Z
    Q1
    FRONTIERS IN IMMUNOLOGY
    2021.
    DOI:10.3389/fimmu.2021.663187 (Copy DOI)
    3.
    A COVID-19-association-dependent categorization of death causes in 100 autopsy cases
    Danics, K;Pesti, A;Töro, K;Kiss-Dala, N;Szlávik, J;Lakatos, B;Radnai, A;Balázs, T;Bacskai, M;Dobi, D;Várkonyi, T;Glasz, T;Lotz, G;Kiss, A;Schaff, Z;Vályi-Nagy, I
    D1
    GEROSCIENCE
    2021.
    DOI:10.1007/s11357-021-00451-w (Copy DOI)
    4.
    Decreased circulating dipeptidyl peptidase-4 enzyme activity is prognostic for severe outcomes in COVID-19 inpatients
    Nádasdi, A;Sinkovits, G;Bobek, I;Lakatos, B;Förhécz, Z;Prohászka, ZZ;Réti, M;Arató, M;Cseh, G;Masszi, T;Merkely, B;Ferdinandy, P;Vályi-Nagy, I;Prohászka, Z;Firneisz, G
    Q3
    BIOMARKERS IN MEDICINE
    2022.
    DOI:10.2217/bmm-2021-0717 (Copy DOI)
    5.
    Associations between the von Willebrand Factor-ADAMTS13 Axis, Complement Activation, and COVID-19 Severity and Mortality
    Sinkovits, G;Réti, M;Müller, V;Iványi, Z;Gál, J;Gopcsa, L;Reményi, P;Szathmáry, B;Lakatos, B;Szlávik, J;Bobek, I;Prohászka, ZZ;Förhecz, Z;Mezo, B;Csuka, D;Hurler, L;Kajdácsi, E;Cervenak, L;Kiszel, P;Masszi, T;Vályi-Nagy, I;Prohászka, Z
    Q1
    THROMBOSIS AND HAEMOSTASIS
    2022.
    DOI:10.1055/s-0041-1740182 (Copy DOI)
    6.
    Complement lectin pathway activation is associated with COVID-19 disease severity, independent of MBL2 genotype subgroups
    Hurler, L;Szilágyi, A;Mescia, F;Bergamaschi, L;Mezo, B;Sinkovits, G;Réti, M;Müller, V;Iványi, Z;Gál, J;Gopcsa, L;Reményi, P;Szathmáry, B;Lakatos, B;Szlávik, J;Bobek, I;Prohászka, ZZ;Förhécz, Z;Csuka, D;Kajdácsi, E;Cervenak, L;Kiszel, P;Masszi, T;Vályi-Nagy, I;Wüerzner, R;Lyons, PA;Toonen, EJM;Prohászka, Z
    Q1
    FRONTIERS IN IMMUNOLOGY
    2023.
    DOI:10.3389/fimmu.2023.1162171 (Copy DOI)
    7.
    Understanding clinical outcomes and factors influencing mortality in intensive care unit patients with COVID-19-associated candidemia
    Aydin, S;Mert, A;Yilmaz, M;Al Maslamani, M;Rahimi, BA;Ayoade, F;El-Kholy, A;Belitova, M;Sengel, BE;Jalal, S;Albayrak, A;Alatawi, JA;Szabo, BG;Ganeshan, RS;Nsutebu, E;Poojary, A;Akkoyunlu, Y;Alkan, S;Elik, DB;Eser-Karlidag, G;Santos, L;Moroti, R;Altin, N;Gürbüz, E;Ulusoy, TÜ;Sipahi, OR;Çaskurlu, H;Esmaoglu, A;Lakatos, B;El-Sayed, NM;Marino, A;Cascio, A;Mihai, A;Dumitru, IM;Pshenichnaya, N;Ripon, RK;Makek, MJ;Rashid, N;Baljic, R;Dascalu, C;Sincan, G;Kizmaz, YU;Madendere, B;Erdem, H
    Q1
    MYCOSES
    2024.
    DOI:10.1111/myc.13687 (Copy DOI)
    Semmelweis University authors: Szabó, Bálint Gergely, Lakatos, Botond,
    Semmelweis University departments: Semmelweis University,
    8.
    Invasive fungal infections among critically ill adult COVID-19 patients: First experiences from the national centre in Hungary
    Szabo, BG;Lakatos, B;Bobek, I;Szabo, E;Szlavik, J;Vályi-Nagy, I
    Q3
    JOURNAL DE MYCOLOGIE MEDICALE
    2021.
    DOI:10.1016/j.mycmed.2021.101198 (Copy DOI)
    Semmelweis University authors: Szabó, Bálint Gergely, Lakatos, Botond,
    Semmelweis University departments: Semmelweis University, School of PhD Studies,
    9.
    Complement Levels at Admission Reflecting Progression to Severe Acute Kidney Injury (AKI) in Coronavirus Disease 2019 (COVID-19): A Multicenter Prospective Cohort Study
    Henry, BM;Sinkovits, G;Szergyuk, I;de Oliveira, MHS;Lippi, G;Benoit, JL;Favaloro, EJ;Pode-Shakked, N;Benoit, SW;Cooper, DS;Muller, V;Ivanyi, Z;Gal, J;Reti, M;Gopcsa, L;Remenyi, P;Szathmary, B;Lakatos, B;Szlavik, J;Bobek, I;Prohaszka, ZZ;Forhecz, Z;Csuka, D;Hurler, L;Kajdacsi, E;Cervenak, L;Mezo, B;Kiszel, P;Masszi, T;Valyi-Nagy, I;Prohaszka, Z
    Q1
    FRONTIERS IN MEDICINE
    2022.
    DOI:10.3389/fmed.2022.796109 (Copy DOI)
    10.
    Osteosynthesis-associated infection of the lower limbs by multidrug-resistant and extensively drug-resistant Gram-negative bacteria: a multicentre cohort study
    Giannitsioti, E;Salles, MJ;Mavrogenis, A;Rodriguez-Pardo, D;Los-Arcos, I;Ribera, A;Ariza, J;del Toro, MD;Nguyen, S;Senneville, E;Bonnet, E;Chan, M;Pasticci, MB;Petersdorf, S;Benito, N;O' Connell, N;García, AB;Skaliczki, G;Tattevin, P;Tufan, ZK;Pantazis, N;Megaloikonomos, PD;Papagelopoulos, P;Soriano, A;Papadopoulos, A
    Q2
    JOURNAL OF BONE AND JOINT INFECTION
    2022.
    DOI:10.5194/jbji-7-279-2022 (Copy DOI)
    Semmelweis University authors: Skaliczki, Gábor, Lakatos, Botond,
    Semmelweis University departments: Semmelweis University, Faculty of Medicine, Department of Orthopedics,
    11.
    Pharmacokinetic and pharmacodynamic considerations of antibiotic therapy among critically ill adult patients with sepsis
    Lili, H;Gergely, SB;Lorinc, Z;Rózsa, H;Péter, A;Balázs, KG;Botond, L
    Q4
    ORVOSI HETILAP
    2024.
    DOI:10.1556/650.2024.33001 (Copy DOI)
    12.
    Where are we with pre-exposure prophylaxis use in Central and Eastern Europe? Data from the Euroguidelines in Central and Eastern Europe (ECEE) Network Group
    Balayan, T;Begovac, J;Skrzat-Klapaczynska, A;Aho, I;Alexiev, I;Bukovinova, P;Salemovic, D;Gokengin, D;Harxhi, A;Holban, T;Jevtovic, D;Kase, K;Lakatos, B;Latysheva, I;Matulionyte, R;Oprea, C;Papadopoulos, A;Rukhadze, N;Sedlacek, D;Tomazic, J;Vassilenko, A;Vasylyev, M;Verhaz, A;Yancheva, N;Yurin, O;Horban, A;Kowalska, JD
    Q1
    HIV MEDICINE
    2021.
    DOI:10.1111/hiv.12960 (Copy DOI)
    Semmelweis University authors: Lakatos, Botond,
    Semmelweis University departments: Semmelweis University,
    13.
    Favipiravir treatment does not influence disease progression among adult patients hospitalized with moderate-to-severe COVID-19: a prospective, sequential cohort study from Hungary
    Szabo, BG;Lenart, KS;Petrik, B;Gaspar, Z;Kiss-Dala, N;Szlavik, J;Valyi-Nagy, I;Lakatos, B
    D1
    GEROSCIENCE
    2021.
    DOI:10.1007/s11357-021-00452-9 (Copy DOI)
    14.
    Secondary infections and long-term outcomes among hospitalized elderly and non-elderly patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and treated with baricitinib: a comparative study from the national centre of Hungary
    Gáspár, Z;Szabó, BG;Andrikovics, H;Ceglédi, A;Rajmon, M;Ibrahám, A;Várnai, Z;Kiss-Dala, N;Szlávik, J;Sinkó, J;Vályi-Nagy, I;Lakatos, B
    D1
    GEROSCIENCE
    2024.
    DOI:10.1007/s11357-024-01099-y (Copy DOI)
    15.
    Laboratory parameters predicting mortality of adult in-patients with COVID-19 associated cytokine release syndrome treated with high-dose tocilizumab
    Lakatos, B;Szabo, BG;Bobek, I;Gopcsa, L;Beko, G;Kiss-Dala, N;Petrik, B;Gaspar, Z;Farkas, BF;Sinko, J;Remenyi, P;Szlavik, J;Valyi-Nagy, I
    Q3
    ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA
    2021.
    DOI:10.1556/030.2021.01526 (Copy DOI)
    16.
    Clinical and Microbiological Outcomes and Follow-Up of Secondary Bacterial and Fungal Infections among Critically Ill COVID-19 Adult Patients Treated with and without Immunomodulation: A Prospective Cohort Study
    Szabó, BG;Czél, E;Nagy, I;Korózs, D;Petrik, B;Marosi, B;Gáspár, Z;Rajmon, M;Di Giovanni, M;Vályi-Nagy, I;Sinkó, J;Lakatos, B;Bobek, I
    D1
    ANTIBIOTICS-BASEL
    2023.
    DOI:10.3390/antibiotics12071196 (Copy DOI)
    17.
    Kinetics of serum C-reactive protein and procalcitonin levels and their connection to outcomes in community-acquired sepsis
    Bence, M;Rebeka, K;Botond, L;Gergely, SB
    Q4
    ORVOSI HETILAP
    2022.
    DOI:10.1556/650.2022.32618 (Copy DOI)
    18.
    Baricitinib vs tocilizumab treatment for hospitalized adult patients with severe COVID-19 and associated cytokine storm: a prospective, investigational, real-world study
    Lakatos, B;Szabó, BG;Bobek, I;Kiss-Dala, N;Gáspár, Z;Riczu, A;Petrik, B;Farkas, BF;Sebestyén, G;Gopcsa, L;Sinkó, J;Reményi, P;Szlávik, J;Mathiász, D;Vályi-Nagy, I
    D1
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
    2022.
    DOI:10.1016/j.ijid.2022.10.037 (Copy DOI)
    19.
    Utilization of expert opinion in infectious diseases clinical guidelines-A meta-epidemiological study
    Nagavci, B;Schwingshackl, L;Martin-Loeches, I;Lakatos, B
    Q1
    PLOS ONE
    2024.
    DOI:10.1371/journal.pone.0306098 (Copy DOI)
    20.
    Reducing the risk of infections in hereditary and acquired complement deficiencies Review of the literature and proposal for best practice in Hungary
    Eva, K;Beáta, O;Andrea, K;János, S;Vera, G;Gergely, K;Zoltán, P;Botond, L
    Q4
    ORVOSI HETILAP
    2023.
    DOI:10.1556/650.2023.32798 (Copy DOI)
    21.
    Transmitted drug resistance in newly diagnosed and treatment-naive HIV type 1-infected patients in Hungary
    Ay, É;Müller, V;Mezei, M;Pocskay, A;Koroknai, A;Müller, D;Gyori, Z;Marschalkó, M;Tóth, B;Kárpáti, S;Lakatos, B;Szlávik, J;Takács, M;Minárovits, J
    Q2
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE
    2020.
    DOI:10.1016/j.jgar.2019.07.014 (Copy DOI)
    22.
    Elethosszan at tarto oltasi strategia mint eszkoz a pandemiak elleni vedekezesben Magyarorszagon
    Irina, U;Viktor, D;Tamás, J;László, N;Tamás, P;Gergely, V;Botond, L;Viktória, S;Judit, L
    Q4
    ORVOSI HETILAP
    2022.
    DOI:10.1556/650.2022.32408 (Copy DOI)
    23.
    Therapeutic drug monitoring of beta-lactam antibiotics in critically ill adult patients. A single-center prospective observational pilot study
    Lorinc, Z;Andrea, R;Júlia, G;Bence, T;Akos, C;Attila, E;Róbert, F;Géllert, K;Lili, H;Gergely, SB;Botond, L
    Q4
    ORVOSI HETILAP
    2023.
    DOI:10.1556/650.2023.32896 (Copy DOI)
    24.
    Gut Microbiome Alteration in HIV/AIDS and the Role of Antiretroviral Therapy-A Scoping Review
    Gáspár, Z;Nagavci, B;Szabó, BG;Lakatos, B
    Q2
    MICROORGANISMS
    2024.
    DOI:10.3390/microorganisms12112221 (Copy DOI)
    25.
    Epidemiology of early infections after autologous hematopoietic stem cell transplantation Analysis of data from 699 patients treated in a Hungarian centre
    Lakatos, B;Szabó, H;Csordás, K;Tatai, G;Nikolova, R;Csomor, J;Reményi, P;Masszi, T;Vályi-Nagy, I;Sinkó, J
    Q4
    ORVOSI HETILAP
    2020.
    DOI:10.1556/650.2020.31638 (Copy DOI)
    26.
    Outcomes of high-risk adult outpatients treated with early remdesivir therapy during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron era: experiences from the national centre of Hungary
    Gáspár, Z;Szabó, BG;Abrahám, A;Várnai, Z;Kiss-Dala, N;Szlávik, J;Sinkó, J;Vályi-Nagy, I;Lakatos, B
    Q2
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    2023.
    DOI:10.1007/s00210-023-02456-y (Copy DOI)
    27.
    COVID-19-associated liver enzyme elevation is probably multifactorial
    Zsófia, G;Gergely, SB;Noémi, KD;János, S;István, VN;Botond, L
    Q4
    ORVOSI HETILAP
    2022.
    DOI:10.1556/650.2022.32590 (Copy DOI)
    28.
    Use of convalescent plasma therapy in hospitalised adult patients with non-critical COVID-19: a focus on the elderly from Hungary
    Kiss-Dala, N;Szabo, BG;Lakatos, B;Reti, M;Szlavik, J;Valyi-Nagy, I
    D1
    GEROSCIENCE
    2022.
    DOI:10.1007/s11357-022-00683-4 (Copy DOI)
    Semmelweis University authors: Kiss-Dala, Noémi, Szabó, Bálint Gergely, Lakatos, Botond,
    Semmelweis University departments: Semmelweis University, School of PhD Studies,
    29.
    Defining expert opinion in clinical guidelines: insights from 98 scientific societies - a methodological study
    Nagavci, B;Gaspár, Z;Lakatos, B
    D1
    BMC MEDICAL RESEARCH METHODOLOGY
    2025.
    DOI:10.1186/s12874-025-02534-0 (Copy DOI)
    30.
    Extracorporeal Photopheresis as a Possible Therapeutic Approach for Adults with Severe and Critical COVID-19 Non-Responsive to Standard Treatment: A Pilot Investigational Study
    Szabó, BG;Reményi, P;Tasnády, S;Korózs, D;Gopcsa, L;Réti, M;Várkonyi, A;Sinkó, J;Lakatos, B;Szlávik, J;Beko, G;Bobek, I;Vályi-Nagy, I
    Q1
    JOURNAL OF CLINICAL MEDICINE
    2023.
    DOI:10.3390/jcm12155000 (Copy DOI)
    31.
    Anti-Inflammatory Cytokine Profiles in Thrombotic Thrombocytopenic Purpura-Differences Compared to COVID-19
    Demeter, F;Bihari, G;Vadicsku, D;Sinkovits, G;Kajdácsi, E;Horváth, L;Réti, M;Müller, V;Iványi, Z;Gál, J;Gopcsa, L;Reményi, P;Szathmáry, B;Lakatos, B;Szlávik, J;Bobek, I;Prohászka, ZZ;Förhécz, Z;Masszi, T;Vályi-Nagy, I;Prohászka, Z;Cervenak, L
    D1
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
    2024.
    DOI:10.3390/ijms251810007 (Copy DOI)
    32.
    Characteristics of Enterococcus species bloodstream infections among adults with and without onco-hematological malignancies: Experiences from the national center of Hungary
    Marosi, B;Kádár, B;Bruzsa, A;Kocsis, L;Kamotsay, K;Sinkó, J;Szabó, BG;Lakatos, B
    Q2
    EUROPEAN JOURNAL OF MICROBIOLOGY AND IMMUNOLOGY
    2024.
    DOI:10.1556/1886.2024.00011 (Copy DOI)
    33.
    Prevention of Streptococcus pneumoniae infections in adults
    Mészner, Z;Lakatos, B;Ludwig, E
    Q4
    ORVOSI HETILAP
    2024.
    DOI:10.1556/650.2024.33200 (Copy DOI)
    Semmelweis University authors: Lakatos, Botond, Ludwig, Endre,
    Semmelweis University departments: Semmelweis University, Faculty of Medicine, Belgyógyászati és Hematológiai Klinika,
    34.
    Clinical and microbiological characteristics and follow-up of invasive Listeria monocytogenes infection among hospitalized patients: real-world experience of 16 years from Hungary
    Kiss, R;Marosi, B;Korózs, D;Petrik, B;Lakatos, B;Szabó, BG
    Q2
    BMC MICROBIOLOGY
    2024.
    DOI:10.1186/s12866-024-03478-z (Copy DOI)
    35.
    Antimicrobial Resistance and Migration: Interrelation Between Two Hot Topics in Global Health
    Cotugno, S;De Vita, E;Frallonardo, L;Novara, R;Papagni, R;Asaduzzaman, M;Segala, FV;Veronese, N;Nicastri, E;Morea, A;Farkas, FB;Lakatos, B;Iatta, R;Putoto, G;Saracino, A;Di Gennaro, F
    Q2
    ANNALS OF GLOBAL HEALTH
    2025.
    DOI:10.5334/aogh.4628 (Copy DOI)
    36.
    Mpox across countries from Central and Eastern Europe - 2022 outbreak
    Ianache, Irina; Skrzat-Klapaczynska, Agata; Jilich, David; Fleischhans, Lukas; Gmizic, Ivana; Ranin, Jovan; Papadopoulos, Antonios; Protopapas, Konstantinos; Mulabdic, Velida; Lakatos, Botond; Nagy, Eva Livia; Begovac, Josip; Holban, Tiberiu; Sevgi, Dilek Yildiz; Cicic, Alma; Yancheva, Nina; Sojak, Lubomir; Rukhadze, Nino; Kowalska, Justyna; Oprea, Cristiana;
    Q1
    TRAVEL MEDICINE AND INFECTIOUS DISEASE 1477-8939 1873-0442
    2024.
    DOI:10.1016/j.tmaid.2024.102719 (Copy DOI)
    Semmelweis University authors: Lakatos, Botond,
    Semmelweis University departments: Semmelweis University, Faculty of Medicine, Belgyógyászati és Hematológiai Klinika,
    37.
    Factors affecting mortality in COVID-19-associated pulmonary aspergillosis: An international ID-IRI study
    Sahin, Meyha; Yilmaz, Mesut; Mert, Ali; Emecen, Ahmet Naci; Rahman S. Al Maslamani, Muna A.; Mahmoud A. Hashim, Samar; Ittaman, Ajithkumar Valooparambil; Wadi Al Ramahi, Jamal; Gergely Szabo, Balint; Konopnicki, Deborah; Baskol Elik, Dilsah; Lakatos, Botond; Sipahi, Oguz Resat; Khedr, Reham; Jalal, Sabah; Pshenichnaya, Natalia; Magdalena, Dumitru Irina; El-Kholy, Amani; Khan, Ejaz Ahmed; Alkan, Sevil; Hakamifard, Atousa; Sincan, Gulden; Esmaoglu, Aliye; Makek, Mateja Jankovic; Gurbuz, Esra; Lisk...
    Q1
    HELIYON 2405-8440
    2024.
    DOI:10.1016/j.heliyon.2024.e34325 (Copy DOI)
    38.
    Felnőtt betegek farmakokinetikai-farmakodinamikai célértékek segítségével vezérelt intravénás kezelése vankomicinnel
    Holub, Lili; Karvaly, Gellért Balázs; Závorszky, Lőrinc; Kristóf, Katalin; Tóth, Ákos; Tóth, Kinga; Lovász, Boglárka; Kassa, Csaba; Vásárhelyi, Barna; Lakatos, Botond; Szabó, Bálint Gergely;
    Q4
    ORVOSI HETILAP 0030-6002 1788-6120
    2025.
    DOI:10.1556/650.2025.33279 (Copy DOI)
    39.
    Az új típusú koronavírus okozta megbetegedés (COVID–19): összefoglaló hematológusoknak II. – a diagnosztika, terápia és prevenció lehetőségei
    Szabó, Bálint Gergely; Bobek, Ilona; Réti, Marienn; Gopcsa, László; Mathiász, Dóra; Lakatos, Botond; Bekő, Gabriella; Pető, Mónika; Sinkó, János; Mikala, Gábor; Kis, Zoltán; Szlávik, János; Reményi, Péter; Vályi-Nagy, István;
    HEMATOLÓGIA-TRANSZFUZIOLÓGIA 1786-5913
    2020.
    DOI:10.1556/2068.2020.53.2.5 (Copy DOI)
    40.
    Az új típusú koronavírus okozta megbetegedés (COVID–19): összefoglaló hematológusoknak I. – virológia, molekuláris patogenezis és klinikum
    Szabó, Bálint Gergely; Bobek, Ilona; Réti, Marienn; Gopcsa, László; Mathiász, Dóra; Lakatos, Botond; Bekő, Gabriella; Pető, Mónika; Sinkó, János; Mikala, Gábor; Kis, Zoltán; Szlávik, János; Reményi, Péter; Vályi-Nagy, István;
    HEMATOLÓGIA-TRANSZFUZIOLÓGIA 1786-5913
    2020.
    DOI:10.1556/2068.2020.53.2.4 (Copy DOI)
    41.
    Simultaneous effective treatment of critical COVID-19 disease and newly diagnosed high-risk multiple myeloma with thalidomide, methylprednisolone, tocilizumab and baricitinib: is it clinically feasible?
    SZABO, Balint G.; LORINCZI, Csaba; SZANKA, Judit; LAKATOS, Botond; SINKO, Janos; SZLAVIK, Janos; MIKALA, Gabor;
    Q2
    MINERVA MEDICA 0026-4806 1827-1669
    2021.
    DOI:10.23736/S0026-4806.20.07050-0 (Copy DOI)
    Semmelweis University authors: Szabó, Bálint Gergely, Lakatos, Botond, Sinkó, János, Mikala, Gábor,
    Semmelweis University departments: Semmelweis University, School of PhD Studies,
    42.
    Agyi myeloma képét utánzó toxoplasmosis
    Nagy, Eszter; Ceglédi, Andrea; Szabó, Bálint Gergely; Lakatos, Botond; Kiss Anita, Viktória; Kozma, András; Balogh, Attila; Rajnai, Hajnalka; Reményi, Péter; Mikala, Gábor;
    HEMATOLÓGIA-TRANSZFUZIOLÓGIA 1786-5913
    2022.
    DOI:10.1556/2068.2022.00142 (Copy DOI)
    43.
    Ten golden rules for optimal antibiotic use in hospital settings : the WARNING call to action
    Sartelli, Massimo; , ; Barie, Philip S; Coccolini, Federico; Abbas, Mohamed; Abbo, Lilian M; Abdukhalilova, Gulnora K; Abraham, Yishak; Abubakar, Salisu; Abu-Zidan, Fikri M; Adebisi, Yusuff Adebayo; Adamou, Harissou; Afandiyeva, Gulara; Agastra, Ervis; Alfouzan, Wadha A; Al-Hasan, Majdi N; Ali, Sajjad; Ali, Syed Muhammad; Allaw, Fatima; Allwell-Brown, Gbemisola; Amir, Afreenish; Amponsah, Obed Kwabena Offe; Al Omari, Abdelkarim; Ansaloni, Luca; Ansari, Shamshul; Arauz, Ana Belen; Augustin, Goran...
    D1
    WORLD JOURNAL OF EMERGENCY SURGERY 1749-7922 1749-7922
    2023.
    DOI:10.1186/s13017-023-00518-3 (Copy DOI)
    Semmelweis University authors: Lakatos, Botond,
    Semmelweis University departments: Semmelweis University, Faculty of Medicine, Belgyógyászati és Hematológiai Klinika,

    Navigation

    Main page

    Publication search

    Department ranking

    Author ranking

    Author search

    Articles recently published in SJR D1 journals

    Top papers of the university

    Top field weighted citation impact publications

    Highly Cited Articles of Semmelweis University

    Semmelweis Publications
    Release: 2025_5
    Department data last refreshed at: 28.04.2025
    Author data last refreshed at: 28.04.2025
    (c) Semmelweis University - Central Library